Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Odair Braz Júnior und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology Department, Universidade Federal do Paraná (UFPR), Curitiba, 81.531-980, Brazil. Hauptthemen laut MEDLINE: Mannans, Antineoplastic Agents, Melanoma, Melanoma, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo, Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior.
Abstract (Originalsprache)
Melanoma is the most aggressive skin cancer, with a high metastatic potential and limited treatment options in advanced stages. Polysaccharides are promising antitumor agents, and therefore, this study investigated a galactomannan from guar gum hydrolysis (GGH) and its sulfated derivative (GGHS) for their antimelanoma and immunostimulatory effects. GGH shares structural similarity with DAVANAT, a galectin-1 ligand with anticolorectal cancer activity, while GGHS has anticoagulant properties, like heparin used in cancer patients. In vitro, 100 μg/mL GGH or GGHS inhibited melanoma cell invasion, increased adhesion, and reduced colony size, while GGHS also reduced proliferation. Both compounds bind galectin-3 and -1, but only GGH suppressed tumor progression in mice. Both treatments stimulated macrophage proinflammatory responses, including reactive oxygen species production and cytokine secretion. Although in vitro lymphocyte proliferation was not observed, CD3+ cells increased in the metastatic lungs. These results suggest GGH and GGHS as immunostimulatory agents, with GGH as potential melanoma adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cell Biology Department, Universidade Federal do Paraná (UFPR), Curitiba, 81.531-980, Brazil.
- Biochemistry Department, Universidade Federal do Paraná (UFPR), Curitiba, 81.531-980, Brazil.
- School of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo (USP), Ribeirão Preto, 14040-903, Brazil.
ORCID-Profile: Carolina Camargo de Oliveira
Förderung
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
Zitieren
APA
Júnior, O. B., Cristal, A. M., Bellan, D. L., Rossi, G. R., Biscaia, S. M. P., Ribeiro, C. L. G., Gonçalves Dos Santos, J., da Cruz, A. F., Buzzo, J. L. A., Barddal, H., Cipriani, T. R., Dias-Baruffi, M., Trindade, E. D. S., Simas, F. F., & Camargo de Oliveira, C. (2025). Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00290
Vancouver
Júnior OB, Cristal AM, Bellan DL, Rossi GR, Biscaia SMP, Ribeiro CLG, et al. Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00290
BibTeX
@article{Jnior2025,
author = {Júnior, Odair Braz and Cristal, Aline Miranda and Bellan, Daniel de Lima and Rossi, Gustavo Rodrigues and Biscaia, Stellee Marcela Petris and Ribeiro, Camila Laís Gonçalves and Gonçalves Dos Santos, Jacqueline and da Cruz, Anderson Fraga and Buzzo, João Luiz Aldinucci and Barddal, Helyn and Cipriani, Thales R and Dias-Baruffi, Marcelo and Trindade, Edvaldo da Silva and Simas, Fernanda Fogagnoli and Camargo de Oliveira, Carolina},
title = {Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00290}
}
EUVIMED